107 related articles for article (PubMed ID: 22495176)
1. MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type.
Pham-Ledard A; Cappellen D; Martinez F; Vergier B; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2012 Aug; 132(8):2118-20. PubMed ID: 22495176
[No Abstract] [Full Text] [Related]
2. High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type.
Pham-Ledard A; Beylot-Barry M; Barbe C; Leduc M; Petrella T; Vergier B; Martinez F; Cappellen D; Merlio JP; Grange F
JAMA Dermatol; 2014 Nov; 150(11):1173-9. PubMed ID: 25055137
[TBL] [Abstract][Full Text] [Related]
3. Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing.
Mareschal S; Pham-Ledard A; Viailly PJ; Dubois S; Bertrand P; Maingonnat C; Fontanilles M; Bohers E; Ruminy P; Tournier I; Courville P; Lenormand B; Duval AB; Andrieu E; Verneuil L; Vergier B; Tilly H; Joly P; Frebourg T; Beylot-Barry M; Merlio JP; Jardin F
J Invest Dermatol; 2017 Sep; 137(9):1984-1994. PubMed ID: 28479318
[TBL] [Abstract][Full Text] [Related]
4. MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.
Choi JW; Kim Y; Lee JH; Kim YS
Hum Pathol; 2013 Jul; 44(7):1375-81. PubMed ID: 23380077
[TBL] [Abstract][Full Text] [Related]
5. Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.
Zhou XA; Louissaint A; Wenzel A; Yang J; Martinez-Escala ME; Moy AP; Morgan EA; Paxton CN; Hong B; Andersen EF; Guitart J; Behdad A; Cerroni L; Weinstock DM; Choi J
J Invest Dermatol; 2018 Nov; 138(11):2365-2376. PubMed ID: 29857068
[TBL] [Abstract][Full Text] [Related]
6. Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma.
van Galen JC; Hoefnagel JJ; Vermeer MH; Willemze R; Dijkman R; Tensen CP; de Boer WP; Meijer CJ; Oudejans JJ
J Pathol; 2008 Jul; 215(3):340-6. PubMed ID: 18498125
[TBL] [Abstract][Full Text] [Related]
7. MYD88 Somatic Mutation Is a Diagnostic Criterion in Primary Cutaneous Large B-Cell Lymphoma.
Menguy S; Gros A; Pham-Ledard A; Battistella M; Ortonne N; Comoz F; Balme B; Szablewski V; Lamant L; Carlotti A; Lorton MH; de Muret A; Le Gall F; Franck F; Croue A; Cappellen D; Beylot-Barry M; Merlio JP; Vergier B
J Invest Dermatol; 2016 Aug; 136(8):1741-1744. PubMed ID: 27189828
[No Abstract] [Full Text] [Related]
8. [Combination of zanubrutinib and rituximab in the treatment of primary cutaneous diffuse large B-cell lymphoma leg type with CD79B and MYD88 mutations: a case report].
Zhong GC; Yu XN; Li J; Chen CY
Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):258. PubMed ID: 37356991
[No Abstract] [Full Text] [Related]
9. Novel Mutations Involving NF-κB and B-Cell Signaling Pathways in Primary Cutaneous Large B-Cell Lymphoma, Leg-Type and Comparison with Sézary Syndrome.
Kim EJ; Lewis DJ; Duvic M
J Invest Dermatol; 2017 Sep; 137(9):1831-1833. PubMed ID: 28843295
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-κB pathway-activating gene aberrancies in primary cutaneous large B-cell lymphoma, leg type.
Koens L; Zoutman WH; Ngarmlertsirichai P; Przybylski GK; Grabarczyk P; Vermeer MH; Willemze R; Jansen PM; Schmidt CA; Tensen CP
J Invest Dermatol; 2014 Jan; 134(1):290-292. PubMed ID: 23863863
[No Abstract] [Full Text] [Related]
11. CD79B and MYD88 mutations in diffuse large B-cell lymphoma.
Kim Y; Ju H; Kim DH; Yoo HY; Kim SJ; Kim WS; Ko YH
Hum Pathol; 2014 Mar; 45(3):556-64. PubMed ID: 24444466
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
[TBL] [Abstract][Full Text] [Related]
13. MYD88 expression and L265P mutation in mature B-cell non-Hodgkin lymphomas.
Caner V; Sen Turk N; Baris IC; Cetin GO; Tepeli E; Hacioglu S; Sari I; Zencir S; Dogu MH; Bagci G; Keskin A
Genet Test Mol Biomarkers; 2015 Jul; 19(7):372-8. PubMed ID: 25978699
[TBL] [Abstract][Full Text] [Related]
14. MYD88 (L265P) mutation is an independent prognostic factor for outcome in patients with diffuse large B-cell lymphoma.
Fernández-Rodríguez C; Bellosillo B; García-García M; Sánchez-González B; Gimeno E; Vela MC; Serrano S; Besses C; Salar A
Leukemia; 2014 Oct; 28(10):2104-6. PubMed ID: 24903481
[No Abstract] [Full Text] [Related]
15. Oncogenic MYD88 mutation drives Toll pathway to lymphoma.
Jeelall YS; Horikawa K
Immunol Cell Biol; 2011 Aug; 89(6):659-60. PubMed ID: 21519346
[No Abstract] [Full Text] [Related]
16. IRF4 expression without IRF4 rearrangement is a general feature of primary cutaneous diffuse large B-cell lymphoma, leg type.
Pham-Ledard A; Prochazkova-Carlotti M; Vergier B; Petrella T; Grange F; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 May; 130(5):1470-2. PubMed ID: 20054341
[No Abstract] [Full Text] [Related]
17. 9p21 deletion in primary cutaneous large B-cell lymphoma, leg type, may escape detection by standard FISH assays.
Wiesner T; Obenauf AC; Geigl JB; Vallant EM; Speicher MR; Fink-Puches R; Kerl H; Cerroni L
J Invest Dermatol; 2009 Jan; 129(1):238-40. PubMed ID: 18704105
[No Abstract] [Full Text] [Related]
18. MyD88 Mutation in Elderly Predicts Poor Prognosis in Primary Central Nervous System Lymphoma: Multi-Institutional Analysis.
Takano S; Hattori K; Ishikawa E; Narita Y; Iwadate Y; Yamaguchi F; Nagane M; Akimoto J; Oka H; Tanaka S; Sakata M; Matsuda M; Yamamoto T; Chiba S; Matsumura A
World Neurosurg; 2018 Apr; 112():e69-e73. PubMed ID: 29258950
[TBL] [Abstract][Full Text] [Related]
19. Lack of myeloid differentiation primary response protein MyD88 L265P mutation in primary cutaneous marginal zone lymphoma.
Brenner I; Roth S; Flossbach L; Wobser M; Rosenwald A; Geissinger E
Br J Dermatol; 2015 Dec; 173(6):1527-8. PubMed ID: 26099629
[No Abstract] [Full Text] [Related]
20. Absence of MYD88 L265P mutation in blastic plasmacytoid dendritic cell neoplasm.
Fiandrino G; Arra M; Riboni R; Lucioni M; Dallera E; Arcaini L; Berti E; Paulli M
Br J Dermatol; 2013 Apr; 168(4):883-4. PubMed ID: 23013250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
